FdaApplication
ANDA 210130
Identifiers
- fda_app_no: ANDA210130
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2019-04-19 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EVEROLIMUS | EVEROLIMUS | 5MG | TABLET, FOR SUSPENSION;ORAL |
| EVEROLIMUS | EVEROLIMUS | 2MG | TABLET, FOR SUSPENSION;ORAL |
| EVEROLIMUS | EVEROLIMUS | 3MG | TABLET, FOR SUSPENSION;ORAL |
3 products